Table 1.

Single and concomitant use of drugs with CNS effects at baseline, at follow-up examination and at both times in a population aged ≥65 years with an MMSE total score of 0–23

	Baseline (n = 52)		Follow-up (n = 52)		Both at baseline and follow-up (n = 52)
	n	%	n	%	n	%
Ops	6	12	6	12	2	4
AChs	12	23	14	27	8	15
APs	6	12	8	15	4	8
ADs	5	10	9	17	4	8
BZDs	11	21	15	29	7	13
AEs	1	2	2	4	1	2
At least one of the above drugs	24	46	29	56	8	15